Informing Spectroscopists for Over 40 Years

13th International Conference on Biologics and Biosimilars

24 October 2018 to 25 October 2018
Boston,
United States

This biosimilars conference will look at the facets of current challenges in biosimilar development. This biosimilar conference will focus on multiple aspects of biosimilar product development to successfully deliver safe, potential and efficacious biologic products to the market. The theme is ’Emerging Trends in Biosimilars Approvals, Market and pricing’.

CONFERENCE HIGHLIGHTS

  • Current Challenges in Developing Biosimilars
  • Biosimilars Analytical Strategies
  • Emerging Biosimilars in Therapeutics
  • Regulatory Approach for Biosimilars
  • Legal Issues and BPCI Act
  • Biosimilars Research Pipeline
  • Globalization of Biosimilars
  • Clinical Development Of Biosimilars
  • Intellectual Property Rights
  • Bioequivalence Assessment
  • BCS and IVIVC Based Biowaivers
  • Biosimilar Companies and Market Analysis
  • Challenges in Biosimilars Pharmacovigilance
  • Brexit Effect on Biosimilars